Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells.

Journal of autoimmunity - 1 Feb 2016

Aricha Revital, Reuveni Debby, Fuchs Sara, Souroujon Miriam C

Abstract excerpt

Adoptive transfer of regulatory T (Treg) cells have been employed effectively for suppression of several animal models for autoimmune diseases. In order to employ Treg cell therapy in patients, it is necessary to generate Treg cells from the patient's own cells (autologous) that would be able to suppress effectively the disease in vivo, upon their reintroduction to the patient. Towards this objective, we report...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adoptive Transfer
Share to Cell Communication
Share to Dendritic Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunosuppression Therapy

Share to Lymphoid Tissue

Share to Receptors, Nicotinic

Share to T-Lymphocyte Subsets

Share to T-Lymphocytes, Regulatory

Source

Identifiers

PMID: 26489998
DOI: 10.1016/j.jaut.2015.09.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells.PMID 26489998Read ↗

Ex Vivo Generated Regulatory T Cells Modulate Experimental Autoimmune Myasthenia GravisSemantic proximity Read ↗

Regulatory function of CD4+CD25++ T cells in patients with myasthenia gravis is associated with phenotypic changes and STAT5 signaling: 1,25-Dihydroxyvitamin D3 modulates the suppressor activity.Semantic proximity Read ↗

Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance.Semantic proximity Read ↗

Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis.Semantic proximity Read ↗

Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats.Semantic proximity Read ↗

Direct Proof of the In Vivo Pathogenic Role of the AChR Autoantibodies from Myasthenia Gravis PatientsSemantic proximity Read ↗

B cells produce less IL-10, IL-6 and TNF-α in myasthenia gravis.Semantic proximity Read ↗

Antigen-specific apheresis of pathogenic autoantibodies from myasthenia gravis sera.Semantic proximity Read ↗

Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes.Semantic proximity Read ↗

Suppressed clinical experimental autoimmune myasthenia gravis in bm12 mice is linked to reduced intracellular calcium mobilization and IL-10 and IFN-gamma release by acetylcholine receptor-specific T cells.Semantic proximity Read ↗

Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis.Semantic proximity Read ↗

Autoimmune human T lymphocytes specific for acetylcholine receptor.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.